Total planned funding: $281,768,775
Allocations
Countries/Regions
| Eswatini | $281,768,775 |
Organizational Types
| Private Contractor | $67,535,241 |
| Unknown | $59,991,845 |
| NGO | $51,633,981 |
| University | $42,853,832 |
| Own Agency | $33,572,982 |
| FBO | $7,784,055 |
| Host Country Government Agency | $7,535,230 |
| Multi-lateral Agency | $7,089,130 |
| Other USG Agency | $3,182,479 |
| Implementing Agency | $590,000 |
Program Areas
| Care | $80,823,267 |
| Treatment | $73,858,083 |
| Prevention | $59,077,958 |
| Governance and Systems | $28,462,961 |
| Management and Operations | $21,545,641 |
| Testing | $18,000,865 |
Budget Codes
| HTXS: Treatment: Adult Treatment | $59,345,755 |
| HBHC: Care: Adult Care and Support | $33,792,828 |
| HKID: Care: Orphans and Vulnerable Children | $28,778,149 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $23,204,461 |
| HVMS: Management and Operations | $21,545,641 |
| CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $18,076,144 |
| HVCT: Testing: HIV Testing and Counseling | $18,000,865 |
| HVSI: Strategic Information | $12,044,771 |
| OHSS: Health Systems Strengthening | $11,814,243 |
| HVTB: Care: TB/HIV | $11,061,085 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $8,822,899 |
| HTXD: Treatment: ARV Drugs | $8,797,024 |
| HVAB: Sexual Prevention: Abstinence/Be Faithful | $8,269,483 |
| PDCS: Care: Pediatric Care and Support | $7,191,205 |
| PDTX: Treatment: Pediatric Treatment | $5,715,304 |
| HLAB: Laboratory Infrastructure | $4,603,947 |
| HMBL: Biomedical Prevention: Blood Safety | $704,971 |
| HMIN: Biomedical Prevention: Injection Safety | $0 |
| IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
Top Partner Programs
Not Available:
$45,427,978
Countries/Regions
Columbia University:
$37,782,600
Countries/Regions
Pact, Inc.:
$33,825,302
Countries/Regions
USG Aggregated Agencies:
$18,685,712
Countries/Regions
Chemonics International:
$16,923,647
Countries/Regions